SQUAWK/NEWS
Menu
Live News EQUITY L impact

VNDA (more) Vanda Pharmaceuticals - announces EMA positive opinion for orphan drug designation of imsidolimab for gpp

VNDA (more) Vanda Pharmaceuticals - announces EMA positive opinion for orphan drug designation of imsidolimab for gpp

VNDA

VNDA (more) Vanda Pharmaceuticals - announces EMA positive opinion for orphan drug designation of imsidolimab for gpp